Sour
Jan 29, 2025, 22:05
Teliso-V and osimertinib: the METamorphosis of EGFR-mutant lung cancer?
Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:
“Teliso-V and osimertinib: the METamorphosis of EGFR-mutant lung cancer?
Performing biopsies at treatment resistance is crucial to aid drug development and should be encouraged.”
Teliso-V and osimertinib: the METamorphosis of EGFR-mutant lung cancer? – Annals of Oncology
Authors: S.P.L. Saw
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 26, 2025, 17:54
Jun 26, 2025, 17:47
Jun 26, 2025, 17:29
Jun 26, 2025, 14:50
Jun 26, 2025, 14:20